Long-term Treatment With Tenofovir Alafenamide for Chronic Hepatitis B Results in High Rates of Viral Suppression and Favorable Renal and Bone Safety.
Henry L Y ChanMaria Buti FerretYoung-Suk LimKosh AgarwalPatrick MarcellinMaurizia Rossana BrunettoWan-Long ChuangHarry L A JanssenScott FungNamiki IzumiDzhamal AbdurakhmanovMaciej JabłkowskiMustafa K CelenXiaoli MaFlorin CaruntuJohn F FlahertyFrida AbramovHongyuan WangGregory CamusAnu OsinusiCalvin Q PanDr ShalimarWai-Kay SetoEdward J GanePublished in: The American journal of gastroenterology (2023)
Long-term TAF treatment resulted in high rates of viral suppression, no resistance, and favorable renal and bone safety.